Status:
COMPLETED
Technology-enhanced Transitional Palliative Care for Family Caregivers
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Palliative Care
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect and cost of technology-enhanced transitional palliative care on family caregivers who provide care to a loved one after a hospitalization.
Detailed Description
There will be two groups in this randomized control study: technology-enhanced group and usual care group. The total amount of subjects includes both the palliative care recipients and the family care...
Eligibility Criteria
Inclusion
- Adult family caregiver of adult patient hospitalized at Mayo Clinic
- Receives in-hospital palliative care consult
- Family caregiver lives in a Minnesota or Iowa county that is designated as medically under served or rural area
Exclusion
- Family caregivers who live in Rochester, Minnesota. (Rochester, Minnesota is not considered a medically under served or rural area.)
- Patients with left ventricular assistive devices, documented chronic pain, use of home infusion pain pumps, or documented addictive behaviors.
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2022
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT03339271
Start Date
March 20 2018
End Date
July 5 2022
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905